Detalles de la búsqueda
1.
Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: an integrated analysis.
Psychiatry Clin Neurosci
; 68(7): 498-505, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24417745
2.
A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation.
BMC Psychiatry
; 13: 20, 2013 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-23311957
3.
Efficacy and safety of olanzapine for treatment of patients with bipolar depression: Japanese subpopulation analysis of a randomized, double-blind, placebo-controlled study.
BMC Psychiatry
; 13: 138, 2013 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-23672672
4.
Improved outcomes following a switch to olanzapine treatment from risperidone treatment in a 1-year naturalistic study of schizophrenia patients in Japan.
Psychiatry Clin Neurosci
; 66(4): 313-21, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22624736
5.
An open-label, dose-titration tolerability study of atomoxetine hydrochloride in Japanese adults with attention-deficit/hyperactivity disorder.
Psychiatry Clin Neurosci
; 65(1): 55-63, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21265936
6.
Erratum: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation.
BMC Psychiatry
; 14: 313, 2014 Dec 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-25927447
7.
Efficacy and Safety of Atomoxetine Hydrochloride in Asian Adults With ADHD.
J Atten Disord
; 21(2): 100-109, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24203774
8.
Remission, response, and relapse rates in patients with acute schizophrenia treated with olanzapine monotherapy or other atypical antipsychotic monotherapy: 12-month prospective observational study.
Pragmat Obs Res
; 6: 39-46, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-27774031
9.
Open-label, dose-titration tolerability study of atomoxetine hydrochloride in Korean, Chinese, and Taiwanese adults with attention-deficit/hyperactivity disorder.
Asia Pac Psychiatry
; 6(1): 62-70, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23857916
10.
Long-term safety and tolerability of atomoxetine in Japanese adults with attention deficit hyperactivity disorder.
Asia Pac Psychiatry
; 6(3): 292-301, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24376099
11.
Efficacy and safety of atomoxetine hydrochloride in Korean adults with attention-deficit hyperactivity disorder.
Asia Pac Psychiatry
; 6(4): 386-96, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25345739
12.
Safety and efficacy of olanzapine monotherapy and olanzapine with a mood stabilizer in 18-week treatment of manic/mixed episodes for Japanese patients with bipolar I disorder.
Curr Med Res Opin
; 28(5): 701-13, 2012 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-22356118
13.
Efficacy and safety of olanzapine in the treatment of Japanese patients with bipolar I disorder in a current manic or mixed episode: a randomized, double-blind, placebo- and haloperidol-controlled study.
J Affect Disord
; 136(3): 476-84, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22134043
14.
Schizophrenia Outpatient Health Outcomes study: twelve-month findings.
Pragmat Obs Res
; 3: 27-40, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-27774015
15.
One-year outcomes in schizophrenia after switching from typical antipsychotics to olanzapine in Japan: an observational study.
Pragmat Obs Res
; 3: 41-49, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-27774016
16.
Predictors of antipsychotic monotherapy with olanzapine during a 1-year naturalistic study of schizophrenia patients in Japan.
Clinicoecon Outcomes Res
; 4: 13-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22347801
17.
Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis.
Neuropsychiatr Dis Treat
; 8: 259-66, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22745559
18.
Predictors of continuation with olanzapine during the 1-year naturalistic treatment of patients with schizophrenia in Japan.
Patient Prefer Adherence
; 5: 611-7, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-22259238
19.
A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit/hyperactivity disorder.
J Child Adolesc Psychopharmacol
; 19(4): 341-50, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19702486
Resultados
1 -
19
de 19
1
Próxima >
>>